Zyla patent expiration

1. Arymo Er patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9549899 ZYLA Abuse deterrent pharmaceutical compositions for controlled release
Jul, 2033

(8 years from now)

US9044402 ZYLA Abuse-deterrent pharmaceutical compositions for controlled release
Jul, 2033

(8 years from now)




Drugs and Companies using MORPHINE SULFATE ingredient

Market Authorisation Date: 09 January, 2017

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE

How can I launch a generic of ARYMO ER before it's drug patent expiration?
More Information on Dosage

ARYMO ER family patents

Family Patents

2. Oxaydo patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8409616 ZYLA Extended release opioid abuse deterrent compositions and methods of making same
Nov, 2023

(7 months ago)

US8637540 ZYLA Compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(7 months ago)

US7981439 ZYLA Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
Nov, 2023

(7 months ago)

US7510726 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(7 months ago)

US9492443 ZYLA Abuse deterrent compositions and methods of making same
May, 2024

(a month ago)

US7201920 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Mar, 2025

(7 months from now)




Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 17 June, 2011

Treatment: NA

Dosage: TABLET

How can I launch a generic of OXAYDO before it's drug patent expiration?
More Information on Dosage

OXAYDO family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Sprix patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7476689 ZYLA Therapeutic compositions for intranasal administration which include KETOROLAC
Oct, 2012

(11 years ago)

US6333044 ZYLA Therapeutic compositions for intranasal administration which include KETOROLAC®
Dec, 2018

(5 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) May 14, 2013

Drugs and Companies using KETOROLAC TROMETHAMINE ingredient

Market Authorisation Date: 14 May, 2010

Treatment: Treatment of pain using a nasal spray of ketorolac tromethamine; Treatment of inflammation and pain using a nasal spray of ketorolac tromethamine

Dosage: SPRAY, METERED

How can I launch a generic of SPRIX before it's drug patent expiration?
More Information on Dosage

SPRIX family patents

Family Patents

4. Zorvolex patent expiration

ZORVOLEX IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9173854 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US9017721 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US9186328 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US9180095 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US8999387 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US9180096 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)

US8679544 ZYLA Formulation of diclofenac
Apr, 2030

(5 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 18, 2016
New Indication(I-692) Aug 22, 2017

Drugs and Companies using DICLOFENAC ingredient

Market Authorisation Date: 18 October, 2013

Treatment: Treatment of pain

Dosage: CAPSULE

How can I launch a generic of ZORVOLEX before it's drug patent expiration?
More Information on Dosage

ZORVOLEX family patents

Family Patents